EN DE
Watch Callan JMB Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Callan JMB Inc (CJMB) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Callan JMB Inc stock $0.36, price $0.41, that is 11.2% below the price, quality 32 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials US · ISIN US1311001093

CJ Callan JMB Inc logo Thin data Nov 16, 2026

Callan JMB Inc

CJMB · US

Expensive (fair value 11% below the price), weak company and falling price: meets none of the 3 rules.

Get notified free when this changes
Revenue last quarter 17% below a year ago. 
Fair value $0.3611 · Overvalued 
Quality 32/100 
Falling price (downtrend) 
Weak Growth (revenue 3y −36.9 %/yr in USD) 
Loss-making · -192.0% net margin (TTM) 
Negative free cash flow 
Trails peers (2/9) 
Narrow moat 3/100 · thin data
Thin data 
⟳ CyclicalEstimate
Watch Callan JMB Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$6.32 $0.2840 Fair Value $0.3611 Feb 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

21‑month range $0.2840 – $6.32 · fair‑value band $0.2708 – $0.4513 · the $0.4068 price screens above the $0.3611 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Callan JMB in your weekly email

Every Wednesday you see whether Callan JMB is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States.

Show moreShow less

It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities.

The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; specialty temperature-regulating packaging; technical services; and advanced monitoring sentry technology.

Callan JMB Inc. has strategic partnership with Alabama State University to advance the United States pharmaceutical manufacturing and supply chain resilience. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

Stock analysis

Callan JMB Inc (CJMB) currently trades at $0.4068, while our estimate is $0.3611, 11% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.2708 (bear) to $0.4513 (bull), the price of $0.4068 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 32/100 (below-average quality), in the Industrials sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Callan JMB Inc reported revenue of $5.7M in FY2025 versus $22.8M in FY2022, a compound −36.9%/yr. Reported net income was −$8.0M in FY2025.

Key figures

Market cap $2.9M Micro · P/S ratio 0.56 · EPS (TTM) $−1.97 · Net margin −139% · Return on equity −300% · Return on assets (EBIT) −23.3% (4-year average) · Operating margin −135% · Revenue (TTM) $5.1M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 3 out of 100 (low confidence).

What moves the price

The share trades about 90% below its 52-week high and 43% above its 52-week low.

For context, the median of 10 Industrials peers we cover trades at −37% fair-value upside, at −11%, CJMB screens cheaper than that median.

Fair Value

Bear $0.2708 Fair Value $0.3611 Bull $0.4513
Price $0.4068 · Downside -11.2%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 32/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 28
How much profit the company makes from its sales and capital
Quality Growth 5
Are margins and returns getting better?
Cashflow 2
Do the profits arrive as real cash?
Financial strength 64
Debt, balance sheet and risk of trouble
Investment 84
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 9
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 20
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

  • BuyDavid J CroyleChief Medical Officer, 10% owner2× since Mar 6, 2026: 25,000 shares, avg. $1.76$43,898Mar 20, 2026
  • BuyGerald DialDirector2× since Dec 30, 2025: 12,000 shares, avg. $0.8341$10,009Dec 30, 2025
  • BuyWayne D WilliamsCEO, Chairman and President, Director, 10% owner3× since Dec 10, 2025: 65,343 shares, avg. $1.67$109,258Dec 16, 2025
  • BuyLiberty Smith DukeDirector1,512 shares at $1.54$2,334Dec 9, 2025

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−12.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−36.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
27.7% (2022) → −113.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

CJMB screens overvalued: fair value 11% below the price. Compare with United Parcel Service, Inc →

Compare Callan JMB Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Integrated Freight & Logistics · 215 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 32 · Bottom 25%
Fair Value upside −11.2% · Below median
Profitability
Return on assets −137.9% · Bottom 25%
Net margin (12 months) −192.0% · Bottom 25%
Operating margin (12 months) −135.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −17.4% · Bottom 25%

Valuation Multiplesvs Integrated Freight & Logistics median · lower = cheaper

P/B 1.23× · Cheaper than median
P/S (12 months) 0.56× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)18 · sector 44
FUTURE (revenue growth)0 · sector 48
PAST (return on equity)0 · sector 32
HEALTH (low debt)0 · sector 94
DIVIDEND (yield)0 · sector 63

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Integrated Freight & Logistics stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
S.F. Holding 002352 ¥33.76 ¥45.60 +35% vs CJMB
FedEx Corporation FDX $327.65 $350.86 +7% vs CJMB
United Parcel Service, Inc UPS $111.82 $107.24 −4% vs CJMB
Deutsche Post AG DHL €61.00 €53.62 −12% vs CJMB
Kuehne + Nagel International AG KNIN CHF 234.40 CHF 147.92 −37% vs CJMB
Expeditors International of Washington, Inc EXPD $195.34 $117.46 −40% vs CJMB
Poste Italiane S.p.A PST €25.47 €14.85 −42% vs CJMB
J.B. Hunt Transport Services, Inc JBHT $232.20 $134.78 −42% vs CJMB
DSV A/S DSV kr 1,471 kr 711.95 −52% vs CJMB
FedEx Freight Holding FDXF $132.91 $54.55 −59% vs CJMB

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Callan JMB Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Callan JMB Inc Fair Value". https://www.fairvalue-calculator.com/stock/CJMB

Frequently asked questions

Is Callan JMB Inc (CJMB) overvalued or undervalued?
As of Nov 16, 2026, our estimate of fair value is $0.3611 versus a price of $0.4068, about 11% lower (overvalued).
What is the fair value of CJMB?
Our estimate for Callan JMB Inc is $0.3611 (as of Nov 16, 2026), built from audited fundamentals. The current price: $0.4068.
What is the quality score of CJMB?
Callan JMB Inc has a Quality Score of 32/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Callan JMB Inc (CJMB)?
Our calculated price target is the estimate of $0.3611 (as of Nov 16, 2026). Cautious scenario $0.2708, optimistic scenario $0.4513. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Callan JMB Inc stock forecast for 2026?
Our estimate puts fair value at $0.3611, about 11% lower versus a price of $0.4068 (overvalued). Cautious scenario $0.2708, optimistic scenario $0.4513. The calculation is refreshed regularly with new filings.
What is the revenue of Callan JMB Inc (CJMB)?
Callan JMB Inc reported trailing-twelve-month revenue of about $5.1M (latest available figure, as of Nov 16, 2026).
What is the intrinsic value of Callan JMB Inc (CJMB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Callan JMB Inc it is $0.3611 per share (as of Nov 16, 2026), against a price of $0.4068.
Is Callan JMB Inc stock overvalued or undervalued in 2026?
As of Nov 16, 2026, CJMB trades above its calculated fair value: price $0.4068, fair value $0.3611, a gap of about −11% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CJMB?
No. The price is what the market pays today ($0.4068); the fair value is what the company's own numbers justify ($0.3611). For Callan JMB Inc the two are $0.0457 per share apart. That gap is exactly why we show both numbers side by side.
How much is Callan JMB Inc worth?
The market values Callan JMB Inc at about $2.9M (market capitalisation, as of Nov 16, 2026). Per share that is $0.4068; our models calculate a fair value of $0.3611 per share.
What do the bullish and bearish scenarios say about CJMB?
Our models span a range for Callan JMB Inc: cautious scenario $0.2708, base $0.3611, optimistic $0.4513 per share (as of Nov 16, 2026, price $0.4068). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Callan JMB Inc (CJMB)?
Balance-sheet figures for Callan JMB Inc (as of Nov 16, 2026): return on equity −300.3%. They feed the Quality Score of 32/100, which measures business quality independently of the share price.
How far is CJMB from its 52-week high?
Callan JMB Inc trades at $0.4068, about 90% below its 52-week high of $4.20 and 43% above the low of $0.2840 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of $0.3611 is for.
Which stocks are comparable to Callan JMB Inc?
From the same area (Industrials) we also value United Parcel Service, Inc, Deutsche Post AG, FedEx Corporation, DSV A/S, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Callan JMB Inc stock attractive at the current price?
The data as of Nov 16, 2026: price $0.4068, calculated fair value $0.3611 (−11%), Quality Score 32/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Callan JMB Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Callan JMB Inc (CJMB)?
The closing price on Nov 16, 2026 was $0.4068. Our estimate is $0.3611, about 11% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Callan JMB Inc right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Callan JMB Inc

How large is the market capitalisation of Callan JMB Inc (CJMB)?
The market capitalisation of Callan JMB Inc is $2.9M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Callan JMB Inc (CJMB)?
The price-to-sales ratio of Callan JMB Inc is 0.56 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Callan JMB Inc (CJMB)?
Earnings per share at Callan JMB Inc are $−1.97. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Callan JMB Inc (CJMB)?
The net margin of Callan JMB Inc is −139% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Callan JMB Inc (CJMB)?
The return on equity (ROE) of Callan JMB Inc is −300% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Callan JMB Inc (CJMB)?
On an EBIT basis the return on assets of Callan JMB Inc is −23.3% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Callan JMB Inc (CJMB)?
The operating margin of Callan JMB Inc is −135% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Callan JMB Inc (CJMB)?
Revenue at Callan JMB Inc is down 17.4% versus a year earlier (3y avg −36.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Callan JMB Inc (CJMB) generate?
The free cash flow of Callan JMB Inc is −$5.2M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Callan JMB Inc (CJMB) hold?
Callan JMB Inc holds more cash than debt, $129K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Callan JMB Inc in the live analysis

One click puts Callan JMB Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.